'‫ פרמקולוגיה קלינית שלב א‬:‫מקורות‬






















M. Rowland and TN Tozer Clinical Pharmacokinetics - Concepts and
Applications., 4th Ed , Williams and Wilkins, 1995.
Principles of Clinical Pharmacology, AJ Atkinson, CE Daniels, RL Dedrick,
CV Grudzinskas and SP Markey editors, Academic Press, 2001.
Applied Pharmacokinetics – Principles of Therapeutic Drug Monitoring, WE
Evans, JJ Schentag and WJ Jusko editors, Applied Therapeutics Inc. 1992
Pharmacokinetics, M. Gibaldi and Perrier, Marcel Dekker Inc. 1992.
Guidance for Industry, Bioavailability and Bioequivalence Studies for Orally
Administered Drug Products – General Considerations, FDA Central for Drug
Evaluation Research, 2009.
Guidance for Industry, Statistical Approaches to Establishing Bioequivalence,
FDA Central for Drug Evaluation Research, 2009
Melmon and Morrelli’s. Clinical Pharmacology 2000
Sanford Markey. Principles of Clinical Pharmacology 2001
Preusch P. Principles of Clinical Pharmacology 2001
Goodman and Gilman. The Pharmacological Basis of Therapeutics. 11th Ed.
Katzung BG. Basic and Clinical Pharmacology. 10th Ed. Goldfrank’s
Toxicologic Emergencies, 6th Ed. 1998
Ellenhorn’s Medical Toxicology. Diagnosis and Treatment of Poisoning. 2nd
Ed. 1997
Healthcare Series, Micromedex Inc. (computerized databases)
Evans WE, et al. Applied Pharmacokinetics. Principles of Therapeutic Drug
Monitoring. 1992
Pediatric Pharmacology. Therapeutic Principles in Practice. 2nd Ed. Yaffe &
Aranda Ed. 1992.
Drugs in pregnancy and lactation.6th Ed. Briggs Editor. 2002.
Maternal – Fetal Toxicology. Koren Editor. 2001.
Drugs during pregnancy and lactation. Schaeffer Editor. 2001.
Medication and mothers' milk. 9th Ed. Hale Editor. 2000.
Strom BL. Pharmacoepidemiology. 3rd Ed. 2000.
Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics, 2001
Wood AJJ. Adverse reactions to drugs. In Harrison’s Principles of Internal
Medicine, 17th Ed.
0202 '‫ שלב ב‬+ '‫סקירות עבור שלב א‬




American Academy of Pediatrics, Committee on Drugs. Guidelines for the
ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics
1995; 95: 286- 94
Baudhuin LM, et al. Translation of pharmacogenetics into clinical relevant
testing modalities. Clin Pharmacol Ther 2007; 82: 373-376.
Andrew William J, et al. PhRMA White paper of ADME pharmacogenomics.
J Clin Pharmacol 2008; 48:849-889.
Azuma J, et al. Chronic heart failure: beta blockers and pharmacogenetics. Eur
J Clin Pharmacol 2008; DOI 10.1007/s00228-008-0566-7








Goetz MP, et al. Tamoxifen Pharmacogenomics: The role of CYP2D6 as a
predictor of drug response. Clin Pharmacol Ther 2008; 83: 160-165.
Mei Huang Shiew, et al. Application of pharmacogenomics in clinical
pharmacology. Tox Mechan Methods 2001; 16:89-99.
Monzo M, et al . Pharmacogenomics: a tool for improving cancer
chemotherapy. Clin Transl Oncol 2008; 10: 628-637.
Koren G, Haslam RH.: Pediatric medication errors: predicting and preventing
tenfold disasters. J Clin Pharmacol 1994 ; 34:1043-5
Kauffman RE: Clinical trials in children: problems and pitfalls. Paediatr Drugs
2000; 2:411-8
Peng Zhang, Ling Qin . Potential sue of erythromycin to prevent and treat
prosthetic failure. J Clin Pharmac 2010, 50: 858-860
Verstuyft C, et al. Personalized medicine and antiplatelet therapy: ready for
prime time? European Heart Journal 2009, 30: 1943-163.
Roederer M et al. Applying the genome to national drug fomulary policy in
the developing world. Pharmacogenomics 2010; 11: 633-636